搜索结果：Progress in cardiovascular diseases

Low-dose chest computed tomography (LDCT) inherently captures both pulmonary and cardiac structures, offering a unique opportunity for joint assessment of lung and cardiovascular health. However, most existing approaches treat these domains as independent tasks, overlooking their physiological interplay and shared imaging biomarkers. We propose an Explainable Cross-Disease Reasoning Framework that enables interpretable cardiopulmonary risk assessment from a single LDCT scan. The framework introduces an agentic reasoning process that emulates clinical diagnostic thinking: first perceiving pulmonary findings, then reasoning through established medical knowledge, and finally deriving a cardiovascular judgment with a natural-language rationale. It integrates three components: a Pulmonary Perception Module that summarizes lung abnormalities, an Agentic Pulmonary-to-Cardiac Reasoning Module that infers their cardiovascular implications, and a Cardiac Feature Extractor that encodes structural biomarkers. Their outputs are fused to produce a holistic cardiovascular risk prediction that is both accurate and physiologically grounded. Experiments on the NLST cohort demonstrate that the propos

The inherent nature of patient data poses several challenges. Prevalent cases amass substantial longitudinal data owing to their patient volume and consistent follow-ups, however, longitudinal laboratory data are renowned for their irregularity, temporality, absenteeism, and sparsity; In contrast, recruitment for rare or specific cases is often constrained due to their limited patient size and episodic observations. This study employed self-supervised learning (SSL) to pretrain a generalized laboratory progress (GLP) model that captures the overall progression of six common laboratory markers in prevalent cardiovascular cases, with the intention of transferring this knowledge to aid in the detection of specific cardiovascular event. GLP implemented a two-stage training approach, leveraging the information embedded within interpolated data and amplify the performance of SSL. After GLP pretraining, it is transferred for TVR detection. The proposed two-stage training improved the performance of pure SSL, and the transferability of GLP exhibited distinctiveness. After GLP processing, the classification exhibited a notable enhancement, with averaged accuracy rising from 0.63 to 0.90. Al

Cardiovascular diseases are widespread among patients with chronic noncommunicable diseases and are one of the leading causes of death, including in the working age. The article presents the relevance of the development and application of patient-oriented systems, in which machine learning (ML) is a promising technology that allows predicting cardiovascular diseases. Automated machine learning (AutoML) makes it possible to simplify and speed up the process of developing AI/ML applications, which is key in the development of patient-oriented systems by application users, in particular medical specialists. The authors propose a framework for the application of automatic machine learning and three scenarios that allowed for data combining five data sets of cardiovascular disease indicators from the UCI Machine Learning Repository to investigate the effectiveness in detecting this class of diseases. The study investigated one AutoML model that used and optimized the hyperparameters of thirteen basic ML models (KNeighborsUnif, KNeighborsDist, LightGBMXT, LightGBM, RandomForestGini, RandomForestEntr, CatBoost, ExtraTreesGini, ExtraTreesEntr, NeuralNetFastA, XGBoost, NeuralNetTorch, Light

The detection of cardiovascular diseases (CVD) using machine learning techniques represents a significant advancement in medical diagnostics, aiming to enhance early detection, accuracy, and efficiency. This study explores a comparative analysis of various machine learning algorithms, including Logistic Regression, Decision Tree, Random Forest, Gradient Boosting, Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and XGBoost. By utilising a structured workflow encompassing data collection, preprocessing, model selection and hyperparameter tuning, training, evaluation, and choice of the optimal model, this research addresses the critical need for improved diagnostic tools. The findings highlight the efficacy of ensemble methods and advanced algorithms in providing reliable predictions, thereby offering a comprehensive framework for CVD detection that can be readily implemented and adapted in clinical settings.

Background: Cardiovascular diseases (CVDs) are the leading cause of death globally. The use of artificial intelligence (AI) methods - in particular, deep learning (DL) - has been on the rise lately for the analysis of different CVD-related topics. The use of fundus images and optical coherence tomography angiography (OCTA) in the diagnosis of retinal diseases has also been extensively studied. To better understand heart function and anticipate changes based on microvascular characteristics and function, researchers are currently exploring the integration of AI with non-invasive retinal scanning. There is great potential to reduce the number of cardiovascular events and the financial strain on healthcare systems by utilizing AI-assisted early detection and prediction of cardiovascular diseases on a large scale. Method: A comprehensive search was conducted across various databases, including PubMed, Medline, Google Scholar, Scopus, Web of Sciences, IEEE Xplore, and ACM Digital Library, using specific keywords related to cardiovascular diseases and artificial intelligence. Results: The study included 87 English-language publications selected for relevance, and additional references we

The electrocardiogram (ECG) is a vital tool for diagnosing heart diseases. However, many disease patterns are derived from outdated datasets and traditional stepwise algorithms with limited accuracy. This study presents a method for direct cardiovascular disease (CVD) diagnosis from ECG images, eliminating the need for digitization. The proposed approach utilizes a two-step curriculum learning framework, beginning with the pre-training of a classification model on segmentation masks, followed by fine-tuning on grayscale, inverted ECG images. Robustness is further enhanced through an ensemble of three models with averaged outputs, achieving an AUC of 0.9534 and an F1 score of 0.7801 on the BHF ECG Challenge dataset, outperforming individual models. By effectively handling real-world artifacts and simplifying the diagnostic process, this method offers a reliable solution for automated CVD diagnosis, particularly in resource-limited settings where printed or scanned ECG images are commonly used. Such an automated procedure enables rapid and accurate diagnosis, which is critical for timely intervention in CVD cases that often demand urgent care.

Cardiac magnetic resonance (CMR) is a cornerstone for diagnosing cardiovascular disease. However, it remains underutilized due to complex, time-consuming interpretation across multi-sequences, phases, quantitative measures that heavily reliant on specialized expertise. Here, we present BAAI Cardiac Agent, a multimodal intelligent system designed for end-to-end CMR interpretation. The agent integrates specialized cardiac expert models to perform automated segmentation of cardiac structures, functional quantification, tissue characterization and disease diagnosis, and generates structured clinical reports within a unified workflow. Evaluated on CMR datasets from two hospitals (2413 patients) spanning 7-types of major cardiovascular diseases, the agent achieved an area under the receiver-operating-characteristic curve exceeding 0.93 internally and 0.81 externally. In the task of estimating left ventricular function indices, the results generated by this system for core parameters such as ejection fraction, stroke volume, and left ventricular mass are highly consistent with clinical reports, with Pearson correlation coefficients all exceeding 0.90. The agent outperformed state-of-the-a

Disease progression modeling aims to characterize and predict how a patient's disease complications worsen over time based on longitudinal electronic health records (EHRs). For diseases such as type 2 diabetes, accurate progression modeling can enhance patient sub-phenotyping and inform effective and timely interventions. However, the problem is challenging due to the need to learn continuous-time progression dynamics from irregularly sampled clinical events amid patient heterogeneity (e.g., different progression rates and pathways). Existing mechanistic and data-driven methods either lack adaptability to learn from real-world data or fail to capture complex continuous-time dynamics on progression trajectories. To address these limitations, we propose Temporally Detailed Hypergraph Neural Ordinary Differential Equation (TD-HNODE), which represents disease progression on clinically recognized trajectories as a temporally detailed hypergraph and learns the continuous-time progression dynamics via a neural ODE framework. TD-HNODE contains a learnable TD-Hypergraph Laplacian that captures the interdependency of disease complication markers within both intra- and inter-progression traje

Cardiovascular diseases are the leading cause of mortality globally, necessitating advancements in diagnostic techniques. This study explores the application of wavelet transformation for classifying electrocardiogram (ECG) signals to identify various cardiovascular conditions. Utilizing the MIT-BIH Arrhythmia Database, we employed both continuous and discrete wavelet transforms to decompose ECG signals into frequency sub-bands, from which we extracted eight statistical features per band. These features were then used to train and test various classifiers, including K-Nearest Neighbors and Support Vector Machines, among others. The classifiers demonstrated high efficacy, with some achieving an accuracy of up to 96% on test data, suggesting that wavelet-based feature extraction significantly enhances the prediction of cardiovascular abnormalities in ECG data. The findings advocate for further exploration of wavelet transforms in medical diagnostics to improve automation and accuracy in disease detection. Future work will focus on optimizing feature selection and classifier parameters to refine predictive performance further.

Cardiovascular disease (CVD) remains the foremost cause of mortality worldwide, underscoring the urgent need for intelligent and data-driven diagnostic tools. Traditional predictive models often struggle to generalize across heterogeneous datasets and complex physiological patterns. To address this, we propose a hybrid ensemble framework that integrates deep learning architectures, Convolutional Neural Networks (CNN) and Long Short-Term Memory (LSTM), with classical machine learning algorithms, including K-Nearest Neighbor (KNN) and Extreme Gradient Boosting (XGB), using an ensemble voting mechanism. This approach combines the representational power of deep networks with the interpretability and efficiency of traditional models. Experiments on two publicly available Kaggle datasets demonstrate that the proposed model achieves superior performance, reaching 82.30 percent accuracy on Dataset I and 97.10 percent on Dataset II, with consistent gains in precision, recall, and F1-score. These findings underscore the robustness and clinical potential of hybrid AI frameworks for predicting cardiovascular disease and facilitating early intervention. Furthermore, this study directly supports

Cardiovascular disease remains a leading global cause of mortality, necessitating accurate risk prediction tools. Traditional methods, such as QRISK and the Framingham heart score, exhibit limitations in their ability to incorporate comprehensive patient data, potentially resulting in incomplete risk factor consideration. To address these shortcomings, this study conducts a meticulous review focusing on the application of machine learning models to enhance predictive accuracy. Machine learning models, such as support vector machines, and Random Forest, as well as deep learning techniques like convolutional neural networks and recurrent neural networks, have emerged as promising alternatives. These models offer superior performance, accommodating a broader spectrum of variables and providing precise subgroup-specific predictions. While machine learning integration holds promise for enhancing risk assessment, it presents challenges such as data requirements and computational constraints. Additionally, large language models have revolutionised healthcare applications, augmenting diagnostic precision and patient care. This study examines the core aspects of cardiovascular disease event

Accurate prediction of cardiovascular diseases remains imperative for early diagnosis and intervention, necessitating robust and precise predictive models. Recently, there has been a growing interest in multi-modal learning for uncovering novel insights not available through uni-modal datasets alone. By combining cardiac magnetic resonance images, electrocardiogram signals, and available medical information, our approach enables the capture of holistic status about individuals' cardiovascular health by leveraging shared information across modalities. Integrating information from multiple modalities and benefiting from self-supervised learning techniques, our model provides a comprehensive framework for enhancing cardiovascular disease prediction with limited annotated datasets. We employ a masked autoencoder to pre-train the electrocardiogram ECG encoder, enabling it to extract relevant features from raw electrocardiogram data, and an image encoder to extract relevant features from cardiac magnetic resonance images. Subsequently, we utilize a multi-modal contrastive learning objective to transfer knowledge from expensive and complex modality, cardiac magnetic resonance image, to ch

Cardiovascular diseases (CVD) remain one of the leading causes of hospitalization in Brazil. Exposure to air pollutants such as PM$_{10}$ $μ$m, NO$_2$, and SO$_2$ has been associated with the worsening of these diseases, especially in urban areas. This study evaluated the association between the daily concentration of these pollutants and daily hospitalizations for acute myocardial infarction and cerebrovascular diseases in São Paulo (2010-2019), using generalized additive models with a lag of 0 to 4 days. Two approaches for choosing the degrees of freedom in temporal smoothing were compared: based on pollutant prediction and based on outcome prediction (hospitalizations). Data were obtained from official government databases. The modeling used the quasi-Poisson family in R software (v. 4.4.0). Models with exposure-based smoothing generated more consistent estimates. For PM10μm, the cumulative risk estimate for exposure was 1.08%, while for hospitalization, it was 1.20%. For NO$_2$, the estimated risk was 1.47% (exposure) versus 1.33% (hospitalization). For SO$_2$, a striking difference was observed: 7.66% (exposure) versus 14.31% (hospitalization). The significant lags were on day

Cardiovascular disease (CVDs) is a rapidly rising global concern due to unhealthy diets, lack of physical activity, and other factors. According to the World Health Organization (WHO), primary risk factors include elevated blood pressure, glucose, blood lipids, and obesity. Recent research has focused on accurate and timely disease prediction to reduce risk and fatalities, often relying on predictive models trained on large datasets, which require intensive training. An intelligent system for CVDs patients could greatly assist in making informed decisions by effectively analyzing health parameters. Complex Event Processing (CEP) has emerged as a valuable method for solving real-time challenges by aggregating patterns of interest and their causes and effects on end users. In this work, we propose a fuzzy rule-based system for monitoring clinical data to provide real-time decision support. We designed fuzzy rules based on clinical and WHO standards to ensure accurate predictions. Our integrated approach uses Apache Kafka and Spark for data streaming, and the Siddhi CEP engine for event processing. Additionally, we pass numerous cardiovascular disease-related parameters through CEP en

Graph Retrieval-Augmented Generation (GraphRAG) has emerged as a promising paradigm that organizes external knowledge into structured graphs of entities and relations, enabling large language models (LLMs) to perform complex reasoning beyond text-chunk retrieval. Recent advances have integrated reinforcement learning (RL) into agentic GraphRAG approaches, enabling iterative interactions with knowledge graphs during training. However, existing RL-based methods suffer from two key limitations: (1) they primarily depend on semantic similarity for retrieval, often overlooking the underlying graph topology, and (2) they rely on sparse, outcome-level rewards that fail to capture the quality of intermediate retrieval steps and their dependencies. To address these limitations, we propose HyperGraphPro, a progress-aware agentic framework for graph-based retrieval and multi-step reasoning. HyperGraphPro introduces a structure-aware hypergraph retrieval mechanism that jointly considers semantic relevance and graph connectivity, promoting coherent traversal along multi-hop reasoning paths. Furthermore, we design a progress-based stepwise policy optimization that provides dense learning signals

Cardiovascular diseases (CVDs) are notably prevalent among patients with obstructive sleep apnea (OSA), posing unique challenges in predicting CVD progression due to the intricate interactions of comorbidities. Traditional models typically lack the necessary dynamic and longitudinal scope to accurately forecast CVD trajectories in OSA patients. This study introduces a novel multi-level phenotypic model to analyze the progression and interplay of these conditions over time, utilizing data from the Wisconsin Sleep Cohort, which includes 1,123 participants followed for decades. Our methodology comprises three advanced steps: (1) Conducting feature importance analysis through tree-based models to underscore critical predictive variables like total cholesterol, low-density lipoprotein (LDL), and diabetes. (2) Developing a logistic mixed-effects model (LGMM) to track longitudinal transitions and pinpoint significant factors, which displayed a diagnostic accuracy of 0.9556. (3) Implementing t-distributed Stochastic Neighbor Embedding (t-SNE) alongside Gaussian Mixture Models (GMM) to segment patient data into distinct phenotypic clusters that reflect varied risk profiles and disease progr

Rare diseases are collectively common, affecting approximately one in twenty individuals worldwide. In recent years, rapid progress has been made in rare disease diagnostics due to advances in DNA sequencing, development of new computational and experimental approaches to prioritize genes and genetic variants, and increased global exchange of clinical and genetic data. However, more than half of individuals suspected to have a rare disease lack a genetic diagnosis. The Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium was initiated to study thousands of challenging rare disease cases and families and apply, standardize, and evaluate emerging genomics technologies and analytics to accelerate their adoption in clinical practice. Further, all data generated, currently representing ~7500 individuals from ~3000 families, is rapidly made available to researchers worldwide via the Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) to catalyze global efforts to develop approaches for genetic diagnoses in rare diseases (https://gregorconsortium.org/data). The majority of these families have undergone prior clinical genetic testing

Cardiovascular diseases (CVDs) are currently the leading cause of death worldwide, highlighting the critical need for early diagnosis and treatment. Machine learning (ML) methods can help diagnose CVDs early, but their performance relies on access to substantial data with high quality. However, the sensitive nature of healthcare data often restricts individual clinical institutions from sharing data to train sufficiently generalized and unbiased ML models. Federated Learning (FL) is an emerging approach, which offers a promising solution by enabling collaborative model training across multiple participants without compromising the privacy of the individual data owners. However, to the best of our knowledge, there has been limited prior research applying FL to the cardiovascular disease domain. Moreover, existing FL benchmarks and datasets are typically simulated and may fall short of replicating the complexity of natural heterogeneity found in realistic datasets that challenges current FL algorithms. To address these gaps, this paper presents the first real-world FL benchmark for cardiovascular disease detection, named FedCVD. This benchmark comprises two major tasks: electrocardio

Zero-dimensional cardiovascular models provide a computationally efficient framework for studying global hemodynamic behavior, yet the influence of model complexity on parameter sensitivity remains insufficiently understood. This work investigates two lumped-parameter cardiovascular models, a simplified single-ventricle configuration and a detailed four-chamber representation, to examine how physiological parameter sensitivities vary with model structure. Time-varying elastance functions are used to represent cardiac dynamics, and global sensitivity analysis is performed using Sobol and Morris methods to quantify the impact of key physiological parameters, including venous return, myocardial contractility, total peripheral resistance, and arterial compliance. The results demonstrate that sensitivity rankings differ substantially between the two models, highlighting the role of model granularity and parameter interactions in shaping cardiovascular responses. These findings support sensitivity-driven model reduction and provide a foundation for scalable, non-invasive cardiovascular simulation frameworks.